Select Medical (NYSE:SEM) Shares Gap Up – Here’s Why

Select Medical Holdings Co. (NYSE:SEM) shares gapped up before the market opened on Monday . The stock had previously closed at $17.68, but opened at $18.19. Select Medical shares last traded at $18.38, with a volume of 257,777 shares changing hands.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Royal Bank of Canada lowered their price target on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Friday. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research note on Monday. Finally, UBS Group lowered their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $27.25.

Select Medical Stock Performance

The firm has a fifty day simple moving average of $19.09 and a 200-day simple moving average of $27.91. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.38 billion, a price-to-earnings ratio of 11.16, a P/E/G ratio of 0.64 and a beta of 1.45.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Analysts forecast that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.

Select Medical Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be given a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend is Monday, March 3rd. Select Medical’s payout ratio is 30.30%.

Insider Buying and Selling at Select Medical

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares in the company, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Institutional Trading of Select Medical

A number of large investors have recently made changes to their positions in the company. Mackenzie Financial Corp increased its position in shares of Select Medical by 726.3% in the 4th quarter. Mackenzie Financial Corp now owns 66,497 shares of the health services provider’s stock valued at $1,253,000 after buying an additional 58,449 shares in the last quarter. Neo Ivy Capital Management increased its position in shares of Select Medical by 342,890.0% in the 4th quarter. Neo Ivy Capital Management now owns 34,299 shares of the health services provider’s stock valued at $646,000 after buying an additional 34,289 shares in the last quarter. PharVision Advisers LLC bought a new position in Select Medical during the 4th quarter worth about $685,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Select Medical by 18.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,639 shares of the health services provider’s stock worth $5,912,000 after purchasing an additional 49,281 shares in the last quarter. Finally, Squarepoint Ops LLC increased its holdings in Select Medical by 460.3% during the 4th quarter. Squarepoint Ops LLC now owns 242,756 shares of the health services provider’s stock worth $4,576,000 after purchasing an additional 199,429 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.